| Drug Type Gene editing | 
| Synonyms AAV PLN-R14del, AAV PLN-R14del(Tenaya Therapeutics), AAV-PLN-R14del + [1] | 
| Target | 
| Action modulators | 
| Mechanism PLN modulators(phospholamban modulators) | 
| Therapeutic Areas | 
| Active Indication | 
| Inactive Indication- | 
| Originator Organization | 
| Active Organization | 
| Inactive Organization- | 
| License Organization- | 
| Drug Highest PhasePreclinical | 
| First Approval Date- | 
| Regulation- | 
| Indication | Highest Phase | Country/Location | Organization | Date | 
|---|---|---|---|---|
| Chagas Cardiomyopathy | Preclinical | United States  | 10 May 2024 | |
| Familial Dilated Cardiomyopathy | Preclinical | United States  | 10 May 2024 | 





